Literature DB >> 10403798

Multiple splicing variants of cdc25B regulate G2/M progression.

A R Forrest1, A K McCormack, C P DeSouza, J M Sinnamon, I D Tonks, N K Hayward, K A Ellem, B G Gabrielli.   

Abstract

Progression through G2 phase into mitosis is regulated by the activation of the mitotic cyclin/cdk complexes, which are in turn activated cdc25B and cdc25C phosphatases. Here we report that alternate splicing produces at least five variants of cdc25B, although only cdc25B2 and cdc25B3 are detectable as proteins. Analysis of these two variants shows that cdc25B2 is expressed at lower levels relative to cdc25B3 in all cell lines tested, and the expression of both increased markedly during G2 and mitosis. Overexpression of the catalytically inactive version of either cdc25B variant produced a G2 arrest implicating both in regulating G2/M progression. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403798     DOI: 10.1006/bbrc.1999.0870

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines.

Authors:  Hélène Albert; Eric Battaglia; Carolino Monteiro; Denyse Bagrel
Journal:  Mol Oncol       Date:  2012-07-27       Impact factor: 6.603

2.  RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts.

Authors:  Teresa Raquel Pacheco; Luís Ferreira Moita; Anita Quintal Gomes; Nir Hacohen; Maria Carmo-Fonseca
Journal:  Mol Biol Cell       Date:  2006-07-19       Impact factor: 4.138

3.  Gene expression profile in response to chromium-induced cell stress in A549 cells.

Authors:  J Ye; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

4.  Mitotic phosphorylation of Cdc25B Ser321 disrupts 14-3-3 binding to the high affinity Ser323 site.

Authors:  Puji Astuti; Rose Boutros; Bernard Ducommun; Brian Gabrielli
Journal:  J Biol Chem       Date:  2010-08-27       Impact factor: 5.157

Review 5.  Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.

Authors:  Swastika Sur; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-04-02       Impact factor: 3.396

6.  Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China.

Authors:  Jian-Zhong Shou; Nan Hu; Mikiko Takikita; Mark J Roth; Laura Lee Johnson; Carol Giffen; Quan-Hong Wang; Chaoyu Wang; Yuan Wang; Hua Su; Li-Hui Kong; Michael R Emmert-Buck; Alisa M Goldstein; Stephen M Hewitt; Philip R Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

7.  Mechanisms governing maintenance of Cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus.

Authors:  Veronica Sanchez; Anita K McElroy; Deborah H Spector
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

8.  Total parenteral nutrition leads to alteration of hepatocyte cell cycle gene expression and proliferation in the mouse.

Authors:  Yuko Tazuke; Barbara E Wildhaber; Hua Yang; Joseph Washburn; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

9.  Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.

Authors:  Satomi Mukai; Norikazu Yabuta; Kaori Yoshida; Ayumi Okamoto; Daisaku Miura; Yasuhide Furuta; Takaya Abe; Hiroshi Nojima
Journal:  Sci Rep       Date:  2015-11-04       Impact factor: 4.379

10.  Development of a Novel Nonradioisotopic Assay and Cdc25B Overexpression Cell Lines for Use in Screening for Cdc25B Inhibitors.

Authors:  Gyong Sik Ha; Chung Min Lee; Chan Wha Kim
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.